PT Kalbe Farma Tbk. (IDX: KLBF)
Indonesia
· Delayed Price · Currency is IDR
1,275.00
-45.00 (-3.41%)
Dec 20, 2024, 4:12 PM WIB
PT Kalbe Farma Tbk. Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 32,126,890 | 30,449,134 | 28,933,503 | 26,261,195 | 23,112,655 | 22,633,476 | Upgrade
|
Revenue Growth (YoY) | 5.98% | 5.24% | 10.18% | 13.62% | 2.12% | 7.40% | Upgrade
|
Cost of Revenue | 19,913,240 | 18,897,645 | 17,414,902 | 15,156,133 | 13,038,095 | 12,549,611 | Upgrade
|
Gross Profit | 12,213,650 | 11,551,489 | 11,518,601 | 11,105,061 | 10,074,560 | 10,083,866 | Upgrade
|
Selling, General & Admin | 7,869,444 | 7,591,031 | 7,008,307 | 6,800,994 | 6,238,255 | 6,486,989 | Upgrade
|
Research & Development | 368,379 | 322,297 | 286,805 | 285,159 | 281,059 | 286,655 | Upgrade
|
Other Operating Expenses | -13,631 | -11,322 | -24,730 | -11,954 | -31,247 | -26,331 | Upgrade
|
Operating Expenses | 8,224,192 | 7,902,006 | 7,270,382 | 7,074,199 | 6,488,067 | 6,747,312 | Upgrade
|
Operating Income | 3,989,459 | 3,649,483 | 4,248,219 | 4,030,862 | 3,586,493 | 3,336,553 | Upgrade
|
Interest Expense | -56,265 | -82,958 | -41,226 | -45,486 | -75,837 | -31,055 | Upgrade
|
Interest & Investment Income | 154,400 | 88,218 | 81,827 | 110,792 | 151,559 | 137,938 | Upgrade
|
Earnings From Equity Investments | 19,812 | 26,972 | 36,498 | 80,070 | 21,698 | 5,135 | Upgrade
|
Currency Exchange Gain (Loss) | -8,425 | -55,928 | 155,833 | -20,022 | 29,621 | -21,003 | Upgrade
|
Other Non Operating Income (Expenses) | -12,751 | -12,146 | -13,833 | -11,898 | -13,744 | -9,365 | Upgrade
|
EBT Excluding Unusual Items | 4,086,230 | 3,613,641 | 4,467,318 | 4,144,318 | 3,699,791 | 3,418,203 | Upgrade
|
Impairment of Goodwill | - | - | - | - | -98,054 | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | 15,850 | 12,105 | 20,305 | 42,649 | - | Upgrade
|
Gain (Loss) on Sale of Assets | -1,485 | 1,093 | 3,038 | 7,782 | 19,395 | 16,480 | Upgrade
|
Pretax Income | 4,084,746 | 3,630,584 | 4,482,461 | 4,172,405 | 3,663,782 | 3,434,683 | Upgrade
|
Income Tax Expense | 983,303 | 852,179 | 1,032,378 | 940,397 | 864,159 | 897,081 | Upgrade
|
Earnings From Continuing Operations | 3,101,443 | 2,778,405 | 3,450,083 | 3,232,008 | 2,799,623 | 2,537,602 | Upgrade
|
Minority Interest in Earnings | -21,241 | -11,657 | -67,874 | -48,386 | -66,363 | -30,837 | Upgrade
|
Net Income | 3,080,202 | 2,766,748 | 3,382,210 | 3,183,621 | 2,733,260 | 2,506,765 | Upgrade
|
Net Income to Common | 3,080,202 | 2,766,748 | 3,382,210 | 3,183,621 | 2,733,260 | 2,506,765 | Upgrade
|
Net Income Growth | 4.00% | -18.20% | 6.24% | 16.48% | 9.04% | 2.02% | Upgrade
|
Shares Outstanding (Basic) | 46,116 | 46,256 | 46,516 | 46,873 | 46,873 | 46,875 | Upgrade
|
Shares Outstanding (Diluted) | 46,116 | 46,256 | 46,516 | 46,873 | 46,873 | 46,875 | Upgrade
|
Shares Change (YoY) | -0.86% | -0.56% | -0.76% | -0.00% | -0.00% | - | Upgrade
|
EPS (Basic) | 66.79 | 59.81 | 72.71 | 67.92 | 58.31 | 53.48 | Upgrade
|
EPS (Diluted) | 66.79 | 59.81 | 72.71 | 67.92 | 58.31 | 53.48 | Upgrade
|
EPS Growth | 4.91% | -17.74% | 7.05% | 16.48% | 9.04% | 2.02% | Upgrade
|
Free Cash Flow | 3,993,867 | 2,025,924 | 566,431 | 2,322,036 | 3,294,552 | 769,646 | Upgrade
|
Free Cash Flow Per Share | 86.60 | 43.80 | 12.18 | 49.54 | 70.29 | 16.42 | Upgrade
|
Dividend Per Share | 31.000 | 31.000 | 38.000 | 35.000 | 28.000 | 26.000 | Upgrade
|
Dividend Growth | -18.42% | -18.42% | 8.57% | 25.00% | 7.69% | 0% | Upgrade
|
Gross Margin | 38.02% | 37.94% | 39.81% | 42.29% | 43.59% | 44.55% | Upgrade
|
Operating Margin | 12.42% | 11.99% | 14.68% | 15.35% | 15.52% | 14.74% | Upgrade
|
Profit Margin | 9.59% | 9.09% | 11.69% | 12.12% | 11.83% | 11.08% | Upgrade
|
Free Cash Flow Margin | 12.43% | 6.65% | 1.96% | 8.84% | 14.25% | 3.40% | Upgrade
|
EBITDA | 4,672,431 | 4,314,625 | 4,907,579 | 4,649,287 | 4,146,252 | 3,807,141 | Upgrade
|
EBITDA Margin | 14.54% | 14.17% | 16.96% | 17.70% | 17.94% | 16.82% | Upgrade
|
D&A For EBITDA | 682,972 | 665,142 | 659,360 | 618,424 | 559,759 | 470,587 | Upgrade
|
EBIT | 3,989,459 | 3,649,483 | 4,248,219 | 4,030,862 | 3,586,493 | 3,336,553 | Upgrade
|
EBIT Margin | 12.42% | 11.99% | 14.68% | 15.35% | 15.52% | 14.74% | Upgrade
|
Effective Tax Rate | 24.07% | 23.47% | 23.03% | 22.54% | 23.59% | 26.12% | Upgrade
|
Advertising Expenses | - | 2,110,219 | 2,062,426 | 1,999,089 | 1,635,342 | 1,723,583 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.